{"id":"https://openalex.org/W3013338353","doi":"https://doi.org/10.1136/lupus-2020-eurolupus.18","title":"O4 Baricitinib-induced changes in STAT-associated gene expression in systemic lupus erythematosus","display_name":"O4 Baricitinib-induced changes in STAT-associated gene expression in systemic lupus erythematosus","publication_year":2020,"publication_date":"2020-03-01","ids":{"openalex":"https://openalex.org/W3013338353","doi":"https://doi.org/10.1136/lupus-2020-eurolupus.18","mag":"3013338353"},"language":"en","primary_location":{"id":"doi:10.1136/lupus-2020-eurolupus.18","doi":"https://doi.org/10.1136/lupus-2020-eurolupus.18","is_oa":true,"landing_page_url":"https://doi.org/10.1136/lupus-2020-eurolupus.18","pdf_url":"https://lupus.bmj.com/content/lupusscimed/7/Suppl_1/A9.full.pdf","source":{"id":"https://openalex.org/S2764956401","display_name":"Lupus Science & Medicine","issn_l":"2053-8790","issn":["2053-8790"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oral presentations","raw_type":"proceedings-article"},"volume":null,"type":"conference-paper","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://lupus.bmj.com/content/lupusscimed/7/Suppl_1/A9.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086942556","display_name":"Thomas D\u00f6rner","orcid":"https://orcid.org/0000-0002-6478-7725","observed_orcids":["https://orcid.org/0000-0002-6478-7725"]},"institutions":[{"id":"https://openalex.org/I4210095248","display_name":"German Rheumatism Research Centre","ror":"https://ror.org/00shv0x82","country_code":"DE","type":"facility","lineage":["https://openalex.org/I315704651","https://openalex.org/I4210095248"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Thomas D\u00f6rner","raw_affiliation_strings":["Charite Universit\u00e4tsmedizin Berlin and Deutsches Rheumaforschungszentrum (DRFZ), Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charite Universit\u00e4tsmedizin Berlin and Deutsches Rheumaforschungszentrum (DRFZ), Berlin, Germany","institution_ids":["https://openalex.org/I4210095248","https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015953107","display_name":"Yoshiya Tanaka","orcid":"https://orcid.org/0000-0002-0807-7139","observed_orcids":["https://orcid.org/0000-0002-0807-7139"]},"institutions":[{"id":"https://openalex.org/I188700360","display_name":"University of Occupational and Environmental Health Japan","ror":"https://ror.org/020p3h829","country_code":"JP","type":"education","lineage":["https://openalex.org/I188700360"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiya Tanaka","raw_affiliation_strings":["University of Occupational and Environmental Health Japan, Kitakyushu, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Occupational and Environmental Health Japan, Kitakyushu, Japan","institution_ids":["https://openalex.org/I188700360"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082713013","display_name":"Michelle Petri","orcid":"https://orcid.org/0000-0003-1441-5373","observed_orcids":["https://orcid.org/0000-0003-1441-5373"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Petri","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Baltimore, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Baltimore, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090753435","display_name":"Josef S Smolen","orcid":"https://orcid.org/0000-0002-4302-8877","observed_orcids":["https://orcid.org/0000-0002-4302-8877"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Josef S Smolen","raw_affiliation_strings":["Medical University of Vienna, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071430304","display_name":"Daniel J. Wallace","orcid":"https://orcid.org/0000-0002-2502-1372","observed_orcids":["https://orcid.org/0000-0002-2502-1372"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J Wallace","raw_affiliation_strings":["Cedars-Sinai Medical Center/University California at Los Angeles, Los Angeles"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center/University California at Los Angeles, Los Angeles","institution_ids":["https://openalex.org/I1282927834","https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018393152","display_name":"Ernst R. Dow","orcid":"https://orcid.org/0000-0002-6976-5138","observed_orcids":["https://orcid.org/0000-0002-6976-5138"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ernst R Dow","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079083947","display_name":"Damiano Fantini","orcid":"https://orcid.org/0000-0001-7858-0170","observed_orcids":["https://orcid.org/0000-0001-7858-0170"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Damiano Fantini","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052240068","display_name":"Richard E. Higgs","orcid":"https://orcid.org/0000-0003-0162-4109","observed_orcids":["https://orcid.org/0000-0003-0162-4109"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard E Higgs","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063617539","display_name":"Guilherme Rocha","orcid":"https://orcid.org/0000-0001-6074-9927","observed_orcids":["https://orcid.org/0000-0001-6074-9927"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guilherme Rocha","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103473788","display_name":"Brenda J. Crowe","orcid":"https://orcid.org/0009-0002-5446-8939","observed_orcids":["https://orcid.org/0009-0002-5446-8939"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brenda Crowe","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007939963","display_name":"Robert J. Benschop","orcid":"https://orcid.org/0000-0001-6313-5218","observed_orcids":["https://orcid.org/0000-0001-6313-5218"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J Benschop","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085957178","display_name":"Nicole L Byers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole L Byers","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112984469","display_name":"Maria E. Silk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria E Silk","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001548815","display_name":"Stephanie de Bono","orcid":"https://orcid.org/0000-0003-2058-7139","observed_orcids":["https://orcid.org/0000-0003-2058-7139"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie de Bono","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047950724","display_name":"Robert W. Hoffman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert W Hoffman","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1950,"currency":"GBP","value_usd":2391},"apc_paid":{"value":1950,"currency":"GBP","value_usd":2391},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.11971831,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A9","last_page":"A10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/baricitinib","display_name":"baricitinib","score":1.0},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.9959999918937683},{"id":"https://openalex.org/keywords/stat-signaling-pathway","display_name":"STAT signaling pathway","score":0.6790000200271606},{"id":"https://openalex.org/keywords/stat1","display_name":"STAT1","score":0.9290000200271606},{"id":"https://openalex.org/keywords/stat2","display_name":"STAT2","score":1.0},{"id":"https://openalex.org/keywords/stat4","display_name":"STAT4","score":0.9990000128746033},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.6790000200271606},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.9539999961853027},{"id":"https://openalex.org/keywords/whole-blood-transcriptome","display_name":"whole blood transcriptome","score":0.8159999847412109},{"id":"https://openalex.org/keywords/sledai-2k","display_name":"SLEDAI-2K","score":0.847000002861023},{"id":"https://openalex.org/keywords/clinical-response","display_name":"clinical response","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C2776239193","wikidata":"https://www.wikidata.org/wiki/Q18031750","display_name":"STAT2","level":5,"score":0.9107588529586792},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8954786062240601},{"id":"https://openalex.org/C65439459","wikidata":"https://www.wikidata.org/wiki/Q14914618","display_name":"STAT4","level":5,"score":0.8508610725402832},{"id":"https://openalex.org/C171958077","wikidata":"https://www.wikidata.org/wiki/Q419333","display_name":"STAT protein","level":4,"score":0.6431167721748352},{"id":"https://openalex.org/C2777003663","wikidata":"https://www.wikidata.org/wiki/Q14912030","display_name":"STAT1","level":3,"score":0.5989757776260376},{"id":"https://openalex.org/C2778277574","wikidata":"https://www.wikidata.org/wiki/Q665327","display_name":"stat","level":4,"score":0.5616123676300049},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.5557891130447388},{"id":"https://openalex.org/C157333092","wikidata":"https://www.wikidata.org/wiki/Q902835","display_name":"JAK-STAT signaling pathway","level":4,"score":0.5318198800086975},{"id":"https://openalex.org/C145430368","wikidata":"https://www.wikidata.org/wiki/Q14914613","display_name":"STAT6","level":4,"score":0.5259190797805786},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4662296772003174},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.45890775322914124},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.4401651620864868},{"id":"https://openalex.org/C2775915377","wikidata":"https://www.wikidata.org/wiki/Q188297","display_name":"Lupus erythematosus","level":3,"score":0.4198402762413025},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37622177600860596},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2752040922641754},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.26262274384498596},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21740567684173584},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.20953524112701416},{"id":"https://openalex.org/C2778923194","wikidata":"https://www.wikidata.org/wiki/Q14912019","display_name":"STAT3","level":3,"score":0.18718388676643372},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.0868878960609436},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.078274667263031},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C191732599","wikidata":"https://www.wikidata.org/wiki/Q14865947","display_name":"Interleukin 4","level":3,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/lupus-2020-eurolupus.18","doi":"https://doi.org/10.1136/lupus-2020-eurolupus.18","is_oa":true,"landing_page_url":"https://doi.org/10.1136/lupus-2020-eurolupus.18","pdf_url":"https://lupus.bmj.com/content/lupusscimed/7/Suppl_1/A9.full.pdf","source":{"id":"https://openalex.org/S2764956401","display_name":"Lupus Science & Medicine","issn_l":"2053-8790","issn":["2053-8790"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oral presentations","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/lupus-2020-eurolupus.18","doi":"https://doi.org/10.1136/lupus-2020-eurolupus.18","is_oa":true,"landing_page_url":"https://doi.org/10.1136/lupus-2020-eurolupus.18","pdf_url":"https://lupus.bmj.com/content/lupusscimed/7/Suppl_1/A9.full.pdf","source":{"id":"https://openalex.org/S2764956401","display_name":"Lupus Science & Medicine","issn_l":"2053-8790","issn":["2053-8790"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oral presentations","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3013338353.pdf","grobid_xml":"https://content.openalex.org/works/W3013338353.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3092452074","https://openalex.org/W2952447380","https://openalex.org/W4281394161","https://openalex.org/W4285390200","https://openalex.org/W4386278373","https://openalex.org/W3038510905","https://openalex.org/W4415373347","https://openalex.org/W7140136254","https://openalex.org/W2900790043","https://openalex.org/W4280596494"],"abstract_inverted_index":{"Background":[0],"Baricitinib,":[1],"an":[2],"oral":[3],"selective":[4],"Janus":[5],"kinase":[6],"(JAK)1":[7],"and":[8,52,67,107,122,127,146,165,179,182,194,246],"2":[9,31],"inhibitor,":[10],"resulted":[11,172],"in":[12,16,28,41,72,94,152,173,176,187,198,210,225,229,239],"significant":[13,142,158,185],"clinical":[14,70,208,237],"improvements":[15],"patients":[17,78,212],"with":[18,69,203,207,233,236],"active":[19,109],"systemic":[20],"lupus":[21],"erythematosus":[22],"(SLE)":[23],"receiving":[24],"standard":[25],"background":[26],"therapy":[27],"the":[29,42,49,161],"phase":[30],"study":[32],"JAHH":[33],"(NCT02708095).":[34],"Baricitinib":[35,169,219],"may":[36,220],"impact":[37,60],"key":[38],"cytokines":[39],"implicated":[40],"pathogenesis":[43],"of":[44,54,61,100,105,144,163,191,200],"SLE":[45,73,153,211,226],"through":[46,227],"effects":[47],"on":[48,63],"JAK/signal":[50],"transducer":[51],"activator":[53],"transcription":[55],"(STAT)":[56],"signaling":[57],"pathway.":[58],"The":[59,196],"baricitinib":[62,86,89,204],"STAT-related":[64,230],"gene":[65,148,231],"expression":[66,137,149,199],"associations":[68],"response":[71],"were":[74,79,97],"evaluated.":[75],"Methods":[76],"314":[77],"randomized":[80],"1:1:1":[81],"to":[82],"receive":[83],"once-daily":[84],"placebo,":[85],"2-mg,":[87],"or":[88,113],"4-mg":[90,170],"for":[91],"24":[92,128],"weeks":[93,123],"JAHH.":[95],"Patients":[96],"\u226518":[98],"years":[99],"age,":[101],"had":[102,108],"a":[103,140,157,183],"diagnosis":[104],"SLE,":[106],"disease":[110],"involving":[111],"skin":[112],"joints.":[114],"RNA":[115],"isolated":[116],"from":[117],"whole":[118],"blood":[119],"at":[120,150,167],"baseline":[121,151],"2,":[124],"4,":[125],"12,":[126],"was":[129,156],"analyzed":[130],"using":[131,213],"Affymetrix":[132],"HTA2.0":[133],"array.":[134],"Results":[135],"Gene":[136],"profiling":[138],"demonstrated":[139],"statistically":[141,184],"elevation":[143],"STAT1":[145,164],"STAT2":[147,166],"patients.":[154],"There":[155],"association":[159],"between":[160],"overexpression":[162],"baseline.":[168],"treatment":[171,205],"modest":[174],"reduction":[175,186,197],"STAT1,":[177,192],"STAT2,":[178,193],"STAT4":[180],"expression,":[181,232],"multiple":[188],"genes":[189,202],"downstream":[190],"STAT4.":[195],"STAT-associated":[201],"correlated":[206],"improvement":[209,238],"SLEDAI-2K":[214],"measurements":[215],"(table":[216],"1).":[217],"Conclusions":[218],"partially":[221],"mediate":[222],"its":[223],"effect":[224],"changes":[228,234],"associated":[235],"SLE.":[240],"Acknowledgements":[241],"Funded":[242],"by":[243],"Eli":[244],"Lilly":[245],"Company.":[247]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2020-04-03T00:00:00"}